Earnings

Danaher returns a key business to growth, and we’re raising our stock rating back to buy

Products You May Like

In this photo illustration, a Danaher Corporation logo seen displayed on a tablet. 
Igor Golovnov | SOPA Images | Lightrocket | Getty Images

Danaher shares declined Tuesday despite the life sciences company returning its key bioprocessing business to growth in the third quarter.

Products You May Like

Articles You May Like

State Individual Income Tax Rates and Brackets, 2025
Here’s how much it can cost for one person to live in 12 major cities globally in 2025
Credit card debt hit a record $1.21 trillion — here’s why ‘no one should be surprised,’ expert says
KFC moves U.S. headquarters from Kentucky to Texas
Palo Alto deserves more credit for quarterly results only a year into its new strategy

Leave a Reply

Your email address will not be published. Required fields are marked *